Previous transurethral resection of the prostate is not a contraindication to high-dose rate brachytherapy for prostate cancer

BJU International

Volumn 104, Issue 11, 2009, Pages 1620-1623

  Luo, Hao Lun ^a   Fang, Fu Min ^b   Chuang, Yao Chi ^a   Chiang, Po Hui ^a  

^a CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

^b CHANG GUNG UNIVERSITY COLLEGE OF MEDICINE   (Taiwan)

Author keywords

High dose rate brachytherapy; Morbidity; Outcome; Prostate cancer; TURP

Indexed keywords

PROSTATE SPECIFIC ANTIGEN; STEROID;

ADULT; AGED; ARTICLE; BRACHYTHERAPY; CANCER CONTROL; CANCER PATIENT; CANCER RADIOTHERAPY; CLINICAL EFFECTIVENESS; CONTROLLED STUDY; DYSURIA; EXTERNAL BEAM RADIOTHERAPY; FOLLOW UP; GASTROINTESTINAL SYMPTOM; HEMATURIA; HUMAN; INCONTINENCE; LOWER URINARY TRACT SYMPTOM; MAJOR CLINICAL STUDY; MALE; MORBIDITY; PRIORITY JOURNAL; PROCTITIS; PROSTATE CANCER; RADIATION DOSE; RECTUM HEMORRHAGE; RETROSPECTIVE STUDY; TRANSURETHRAL RESECTION; TREATMENT CONTRAINDICATION; URETHRA STRICTURE; URETHROTOMY; URINE RETENTION; UROGENITAL TRACT DISEASE;

AGED; AGED, 80 AND OVER; BRACHYTHERAPY; COMBINED MODALITY THERAPY; HUMANS; MALE; MIDDLE AGED; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; PROSTATISM; RADIOTHERAPY DOSAGE; RETROSPECTIVE STUDIES; RISK FACTORS; TRANSURETHRAL RESECTION OF PROSTATE; TREATMENT OUTCOME; URINARY RETENTION;

EID: 70449350787     PISSN: 14644096     EISSN: 1464410X     Source Type: Journal    
DOI: 10.1111/j.1464-410X.2009.08664.x     Document Type: Article

References (15)

1. Blasko JC, Ragde H, Grimm PD. Transperineal ultrasound-guided implantation of the prostate: morbidity and complications. Scand J Urol Nephrol Suppl 1991 137 : 113 118
2. Talcott JA, Clark JA, Stark PC, Mitchell SP. Long-term treatment related complications of brachytherapy for early prostate cancer: a survey of patients previously treated. J Urol 2001 166 : 494 499
3. Demanes DJ, Rodriguez RR, Schour L, Brandt D, Altieri G. High-dose-rate intensity-modulated brachytherapy with external beam radiotherapy for prostate cancer: California endocurietherapy's 10-year results. Int J Radiat Oncol Biol Phys 2005 61 : 1306 1316
4. Rubin P, Constine LS, Fajardo LF, Phillips TL, Wasserman TH. RTOG Late Effects Working Group. Overview. Late Effects of Normal Tissues (LENT) scoring system. Int J Radiat Oncol Biol Phys 1995 31 : 1041 1042
5. Roach M rd, Hanks G, Thames H Jr. et al. Defining biochemical failure following radiotherapy with or without hormonal therapy in men with clinically localized prostate cancer: recommendations of the RTOG-ASTRO Phoenix Consensus Conference. Int J Radiat Oncol Biol Phys 2006 65 : 965 974
6. Del Regato JA. Radiotherapy in the conservative treatment of operable and locally inoperable carcinoma of the prostate. Radiology 1967 88 : 761 766
7. Chiang PH, Fang FM, Jong WC, Yu TJ, Chuang YC, Wang HJ. High-dose rate iridium-192 brachytherapy and external beam radiation therapy for prostate cancer with or without androgen ablation. Int J Urol 2004 11 : 152 158
8. Fang FM, Wang YM, Wang CJ, Huang HY, Chiang PH. Comparison of the outcome and morbidity for localized or locally advanced prostate cancer treated by high-dose-rate brachytherapy plus external beam radiotherapy (EBRT) versus EBRT alone. Jpn J Clin Oncol 2008 38 : 474 479
9. Izard MA, Haddad RL, Fogarty GB, Rinks A, Dobbins T, Katelaris P. Six year experience of external beam radiotherapy, brachytherapy boost with a 1Ci (192) Ir source, and neoadjuvant hormonal manipulation for prostate cancer. Int J Radiat Oncol Biol Phys 2006 66 : 38 47
10. Eulau SM, Cavanagh W, Gottesman JE, Mate TP. High dose rate iridium 192 brachytherapy in localized prostate cancer: Results and toxicity with maximum follow-up of 10 years. Int J Radiat Oncol Biol Phys, Suppl 2000 48 : 149
11. Merrick GS, Butler WM, Wallner KE, Galbreath RW, Lief JH, Adamovich E. Effect of cigarette smoking on biochemical outcome after permanent prostate brachytherapy. Int J Radiat Oncol Biol Phys 2004 58 : 1056 1062
12. Wallner K, Lee H, Wasserman S, Dattoli M. Low risk of urinary incontinence following prostate brachytherapy in patients with a prior transurethral prostate resection. Int J Radiat Oncol Biol Phys 1997 37 : 565 569
13. Peddada AV, Jennings SB, Faricy PO, Walsh RA 3rd, White GA, Monroe AT. Low morbidity following high dose rate brachytherapy in the setting of prior transurethral prostate resection. J Urol 2007 178 : 1963 1967
14. Chen YC, Chuang CK, Hsieh ML et al. High-dose-rate brachytherapy plus external beam radiotherapy for T1 to T3 prostate cancer: an experience in Taiwan. Urology 2007 70 : 101 5
15. Prada PJ, Gonzalez H, Fernandez J, Bilbao P. High-dose-rate intensity modulated brachytherapy with external-beam radiotherapy improves local and biochemical control in patients with high-risk prostate cancer. Clin Transl Oncol 2008 10 : 415 421